Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Total Liabilities: 2020-2025

Historic Total Liabilities for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $53.1 million.

  • Insight Molecular Diagnostics' Total Liabilities fell 12.18% to $53.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.1 million, marking a year-over-year decrease of 12.18%. This contributed to the annual value of $47.4 million for FY2024, which is 3.94% down from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Total Liabilities of $53.1 million as of Q3 2025, which was up 7.52% from $49.4 million recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Total Liabilities peaked at $94.3 million during Q4 2021, and registered a low of $22.7 million during Q1 2021.
  • Its 3-year average for Total Liabilities is $49.4 million, with a median of $49.8 million in 2025.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Total Liabilities skyrocketed by 330.10% in 2021 and then slumped by 48.15% in 2023.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Total Liabilities stood at $94.3 million in 2021, then tumbled by 35.88% to $60.5 million in 2022, then dropped by 18.51% to $49.3 million in 2023, then dropped by 3.94% to $47.4 million in 2024, then dropped by 12.18% to $53.1 million in 2025.
  • Its Total Liabilities was $53.1 million in Q3 2025, compared to $49.4 million in Q2 2025 and $50.1 million in Q1 2025.